HIV infections has been the subject of sustained clinical investigation across multiple research sites.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID	Title	Status	Phase
NCT00098722	Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects	COMPLETED	PHASE2/PHASE3
NCT00054717	Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)	COMPLETED	PHASE3
NCT00543725	TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors	COMPLETED	PHASE3
NCT00426660	Expanded Access Program for Maraviroc At Multiple Centers	COMPLETED	PHASE3
NCT00004978	An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy	COMPLETED	PHASE3
NCT00561925	VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients	COMPLETED	PHASE3
NCT00146328	Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects	COMPLETED	PHASE2/PHASE3
NCT01815736	Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants	COMPLETED	PHASE3
NCT00062660	Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection	APPROVED_FOR_MARKETING	—
NCT03446573	Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)	COMPLETED	PHASE3

Related Pages

All HIV infections trials All trials in Surry Hills, Australia